BRTX 1.55 (+6.9%)
US0906556065BiotechnologyBiotechnology

BioRestorative Therapies (BRTX) Stock Highlights

1.55 | +6.9%
2024-12-21 07:40:27
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The companys two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patients bone marrow; and Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Statistics

Range Today
1.42 1.55
Volume Today 16.1K
Range 1 Year
1.03 3.67
Volume 1 Year 172.13M
Range 3 Year
1.03 7.13
Volume 3 Year 243.77M
Range 10 Year
0.4 49000
Volume 10 Year 257.76M

Highlights

Market Capitalization 11.14M (micro)
Floating Shares 5.1M
Current Price 1.55
Price To Earnings -1.76
Price To Revenue -19.77
Price To Book 1.03
Earnings Per Share -0.9
Payout Ratio 0%

Performance

Latest +6.9%
1 Month +7.64%
3 Months -6.06%
6 Months -22.11%
1 Year -15.76%
3 Years -64.93%
5 Years -96.77%
10 Years -100%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.